Polyrizon Limited (PLRZ): יחס מחיר למכירות

Polyrizon Ltd is penetrating the growing personal prevention segment for respiratory infections and allergies. The historical P/S ratio allows for a comparison of market capitalization against annual revenue, where 0.00 serves as the final level marker. Business growth is driven by patents in protective nasal sprays and the robotization of chemical synthesis for bio-barriers, which minimizes manual labor during packaging.

The P/S multiple measures a business's market value relative to its annual revenue, allowing for an assessment of asset monetization efficiency and the extent of overpayment for future earnings. By analyzing the smoothed P/S of a company, an investor determines the asset's valuation stage, which is critically important for Polyrizon Ltd (PLRZ) given its unique nasal barrier technologies and strategic bet on preventive medicine.